311 related articles for article (PubMed ID: 31246997)
1. Characterization of Human Papillomavirus prevalence and risk factors to guide cervical cancer screening in the North Tongu District, Ghana.
Krings A; Dunyo P; Pesic A; Tetteh S; Hansen B; Gedzah I; Wormenor CM; Amuah JE; Behnke AL; Höfler D; Pawlita M; Kaufmann AM
PLoS One; 2019; 14(6):e0218762. PubMed ID: 31246997
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of genotype-specific HPV clearance and reinfection in rural Ghana may compromise HPV screening approaches.
Krings A; Boateng G; Dunyo P; Amuah JE; Adams RA; Adunyame L; Nkansah DO; Wormenor CM; Hansen BT; Gedzah I; Asmah RH; Wiredu EK; Kaufmann AM
Papillomavirus Res; 2019 Jun; 7():45-51. PubMed ID: 30625379
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa.
Denny L; Adewole I; Anorlu R; Dreyer G; Moodley M; Smith T; Snyman L; Wiredu E; Molijn A; Quint W; Ramakrishnan G; Schmidt J
Int J Cancer; 2014 Mar; 134(6):1389-98. PubMed ID: 23929250
[TBL] [Abstract][Full Text] [Related]
4. High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program.
Torres-Poveda K; Ruiz-Fraga I; Madrid-Marina V; Chavez M; Richardson V
BMC Cancer; 2019 Dec; 19(1):1205. PubMed ID: 31823749
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and sociodemographic correlates of cervicovaginal human papillomavirus (HPV) carriage in a cross-sectional, multiethnic, community-based female Asian population.
Khoo SP; Bhoo-Pathy N; Yap SH; Anwar Shafii MK; Hairizan Nasir N; Belinson J; Subramaniam S; Goh PP; Zeng M; Tan HD; Gravitt P; Woo YL
Sex Transm Infect; 2018 Jun; 94(4):277-283. PubMed ID: 29180538
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and risk factors associated with high-risk human papillomavirus infection among women living with HIV (WLWH) at a tertiary health facility in Accra, Ghana.
Agyare Gyane F; Modey E; Maya E; Bonney EY; Abaidoo-Myles A; Paintsil E; Torpey K
PLoS One; 2024; 19(5):e0303535. PubMed ID: 38814956
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, Genotype Distribution and Risk Factors for Cervical Human Papillomavirus Infection in the Grand Tunis Region, Tunisia.
Ardhaoui M; Ennaifer E; Letaief H; Salsabil R; Lassili T; Chahed K; Bougatef S; Bahrini A; El Fehri E; Ouerhani K; Paez Jimenez A; Guizani I; Boubaker MS; Ben Alaya NB
PLoS One; 2016; 11(6):e0157432. PubMed ID: 27299955
[TBL] [Abstract][Full Text] [Related]
9. HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong's largest independent pathology laboratory.
Jiang L; Tian X; Peng D; Zhang L; Xie F; Bi C; Wang R; Wang J; Qi D
PLoS One; 2019; 14(1):e0210311. PubMed ID: 30653566
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of high-risk human papillomavirus infection among women with diabetes mellitus in Accra, Ghana.
Atiase Y; Effah K; Mawusi Wormenor C; Tekpor E; Aku Catherine Morkli E; Boafo E; Yorke E; Aryee R; Essel NOM; Danyo S; Kemawor S; Akpalu J
BMC Womens Health; 2024 Apr; 24(1):260. PubMed ID: 38664791
[TBL] [Abstract][Full Text] [Related]
11. Pre-vaccination prevalence of high-risk human papillomaviruses (HPV) in women from Kosovo and their related sociodemographic characteristics.
Zejnullahu Raçi P; Hošnjak L; Poljak M; Lepej SŽ; Vince A
Ginekol Pol; 2018; 89(9):485-494. PubMed ID: 30318575
[TBL] [Abstract][Full Text] [Related]
12. High frequency of alpha7-HPV in Colombian Caribbean coast women: cervical cancer screening analysis.
Arteaga-Pautt H; Bru-Cordero OE; Ricardo-Caldera D; Espitia-Pérez L; Avilés-Vergara P; Tovar-Acero C; Castaño-Caraballo L; Perdomo-Lara SJ; Zetién-Arteaga HR; Behaine-Bravo V; Soto-De León SC
BMC Infect Dis; 2024 May; 24(1):539. PubMed ID: 38811877
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of human papillomavirus infection among women from quilombo communities in northeastern Brazil.
Nascimento MDDSB; Vidal FCB; Silva MACND; Batista JE; Lacerda Barbosa MDC; Muniz Filho WE; Bezerra GFB; Castro Viana GM; Branco RCC; Brito LMO
BMC Womens Health; 2018 Jan; 18(1):1. PubMed ID: 29291721
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control.
Giuliano AR; Papenfuss M; Abrahamsen M; Denman C; de Zapien JG; Henze JL; Ortega L; Brown de Galaz EM; Stephan J; Feng J; Baldwin S; Garcia F; Hatch K
Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1129-36. PubMed ID: 11700260
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and genotype distribution of human papillomavirus (HPV) in Southwest China: a cross-sectional five years study in non-vaccinated women.
Tang Y; Zheng L; Yang S; Li B; Su H; Zhang LP
Virol J; 2017 Apr; 14(1):84. PubMed ID: 28431558
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus prevalence and distribution in self-collected samples from female university students in Maputo.
Bule YP; Silva J; Carrilho C; Campos C; Sousa H; Tavares A; Medeiros R
Int J Gynaecol Obstet; 2020 May; 149(2):237-246. PubMed ID: 32086940
[TBL] [Abstract][Full Text] [Related]
17. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
[TBL] [Abstract][Full Text] [Related]
18. High-Risk human papillomavirus genotype distribution in the Northern region of Portugal: Data from regional cervical cancer screening program.
Sousa H; Tavares A; Campos C; Marinho-Dias J; Brito M; Medeiros R; Baldaque I; Lobo C; Leça L; Monteiro P; Tavares F; Henrique R
Papillomavirus Res; 2019 Dec; 8():100179. PubMed ID: 31377173
[TBL] [Abstract][Full Text] [Related]
19. Genotypic diversity of anogenital human papillomavirus in women attending cervical cancer screening in Harare, Zimbabwe.
Dube Mandishora RS; Christiansen IK; Chin'ombe N; Duri K; Ngara B; Rounge TB; Meisal R; Ambur OH; Palefsky JM; Stray-Pedersen B; Chirenje ZM
J Med Virol; 2017 Sep; 89(9):1671-1677. PubMed ID: 28390142
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of cervical human papillomavirus infection in healthy women is related to sexual behaviours and educational level: a cross-sectional study.
Tay SK; Oon LL
Int J STD AIDS; 2014 Dec; 25(14):1013-21. PubMed ID: 24648316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
